journal article·2026-06Open access

Dual activation of cuproptosis and excessive autophagy by copper-bismuth metal-organic frameworks-loaded detachable microneedles in oral leukoplakia

Keyi Zhou, Meihua Gao, Yuqi Wan, Beibei Cong, Tingting Zhu, Zhou Ye, Tao Zhang, Wanchun Wang

Abstract

Oral leukoplakia (OLK), a prevalent precancerous lesion with considerable malignant transformation potential, remains a major clinical challenge due to the lack of effective and minimally invasive therapies. Here, we developed novel copper-bismuth metal-organic frameworks (CBM) and incorporated them into a bilayer detachable microneedle system (CBMMN) to achieve localized and sustained delivery. CBM markedly downregulated pyruvate dehydrogenase kinase 3 (PDK3), thereby orchestrating the cooperative activation of cuproptosis and excessive autophagy, which synergistically suppressed the viability of dysplastic oral keratinocytes. In vivo studies further demonstrated that CBMMNs effectively eliminated OLK with minimal systemic toxicity, underscoring their therapeutic efficacy and biosafety. By combining cuproptosis and excessive autophagy, CBMMNs establish a mechanistic foundation distinct from conventional approaches and offer a novel therapeutic approach for OLK management.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Advancements in Transdermal Drug Delivery · Oral Health Pathology and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (71)

Show source-provided references
1. Malignant transformation of oral leukoplakia: a systematic review of observational studies10.1111/jop.12339 ↗
2. Primary clinical evaluation of photodynamic therapy with oral leukoplakia in chinese patients10.3389/fphys.2018.01911 ↗
3. Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review10.1186/s12903-024-04179-9 ↗
4. Cuproptosis in cancer: biological implications and therapeutic opportunities10.1186/s11658-024-00608-3 ↗
5. Copper-related cell death and the role of copper in head and neck squamous cell carcinoma and therapeutic strategies
6. AKT1 phosphorylates FDX1 to promote cuproptosis resistance in triple-negative breast cancer10.1002/advs.202408106 ↗
7. Induction of peroxiredoxin 1 by hypoxia promotes cellular autophagy and cell proliferation in oral leukoplakia via HIF-1α/BNIP3 pathway10.1007/s10735-024-10197-2 ↗
8. Autophagy: regulator of cell death10.1038/s41419-023-06154-8 ↗
9. Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond10.1039/D5CS00083A ↗
10. NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism
11. Tumor microenvironment modulation platform based on composite biodegradable bismuth-manganese radiosensitizer for inhibiting radioresistant hypoxic tumors10.1002/smll.202101015 ↗
12. Autophagy associated cytotoxicity and cellular uptake mechanisms of bismuth nanoparticles in human kidney cells10.1016/j.toxlet.2017.04.014 ↗
13. Injectable bismuth‐based composite enable bone defect repair for osteosarcoma treatment and mild magnetothermal bone regeneration
14. Porphyrin-based metal–organic frameworks: focus on diagnostic and therapeutic applications10.1007/s40097-022-00500-6 ↗
15. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery10.1016/j.jconrel.2015.10.002 ↗
16. A novel Z-Scheme heterostructured Bi2 S3/Cu-TCPP nanocomposite with synergistically enhanced therapeutics against bacterial biofilm infections in periodontitis10.1002/smll.202302547 ↗
17. A novel preclinical in vitro 3D model of oral carcinogenesis for biomarker discovery and drug testing10.3390/ijms24044096 ↗
18. Local delivery of celecoxib/indocyanine green-loaded nanomodulators for combinational photothermal/photodynamic/anti-cyclooxygenase-2 therapy of oral leukoplakia10.1016/j.cej.2025.159734 ↗
19. A hyaluronic acid-based dissolving microneedle patch loaded with 5-aminolevulinic acid for improved oral leukoplakia treatment10.1016/j.colsurfb.2024.114216 ↗
20. Stereochemical expression of Bi 6s2 lone pairs mediates fluoride-ion (De)insertion in tunnel-structured Bi2PdO4 and Bi1.6Pb0.4PtO410.1039/D4SC08111K ↗
21. Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites10.1073/pnas.1222276110 ↗
22. Two-dimensional metal-organic framework nanosheets: synthesis and applications in electrocatalysis and photocatalysis
23. Rapid light response of a novel Bi-based metal–organic framework for bacterial wound infections treatment
24. Ultrafast and parts-per-billion-level MEMS gas sensors by hetero-interface engineering of 2D/2D Cu-TCPP@ZnIn2S4 with enriched surface sulfur vacancies10.1021/acs.nanolett.4c01555 ↗
25. Recent advances in glutathione depletion-enhanced porphyrin-based nMOFs for photodynamic therapy10.3390/pharmaceutics17020244 ↗
26. Applications of nanosheets in frontier cellular research10.3390/nano8070519 ↗
27. Identification of a novel mechanism for meso-tetra (4-carboxyphenyl) porphyrin (TCPP) uptake in cancer cells10.1096/fj.202000197R ↗
28. Malignant transformation of oral leukoplakia: a systematic review of observational studies10.1111/jop.12339 ↗
29. Covalent organic framework eliciting a click-based intracellular copper accumulation cascade for cuproptosis cancer therapy10.1016/j.celbio.2025.100126 ↗
30. Thermal-triggered mitochondrial oxidative phosphorylation-enhanced nanodrug sensitizes cuproptosis with amplified anti-tumor immunity10.1016/j.mattod.2024.11.001 ↗
31. FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery10.1073/pnas.2216722120 ↗
32. Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells10.1016/j.jbc.2023.105075 ↗
33. Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1/ISCA2/ISCU assembly proteins10.1016/j.freeradbiomed.2023.05.017 ↗
34. Proteomic analysis of the copper ion-induced stress response in a human embryonic carcinoma cell line10.1177/1091581812446869 ↗
35. Pinitol improves diabetic foot ulcers in streptozotocin-induced diabetes rats through upregulation of Nrf2/HO-1 signaling10.3390/antiox14010015 ↗
36. In situ transformable fibrillar clusters disrupt intracellular copper metabolic homeostasis by comprehensive blockage of cuprous ions efflux10.1002/smll.202406802 ↗
37. ATPase copper transporting beta (ATP7B) is a novel target for improving the therapeutic efficacy of docetaxel by disulfiram/copper in human prostate cancer10.1158/1535-7163.MCT-23-0876 ↗
38. ATP dependent charge movement in ATP7B Cu+-ATPase is demonstrated by pre-steady state electrical measurements10.1016/j.febslet.2010.10.029 ↗
39. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells10.1038/sj.cdd.4402233 ↗
40. Mechanisms of copper-induced autophagy and links with human diseases10.3390/ph18010099 ↗
41. ATG5: a central autophagy regulator implicated in various human diseases10.1002/cbf.3740 ↗
42. Mechanistic insights into autophagy-dependent cell death (ADCD): a novel avenue for cancer therapy10.3390/cells14141072 ↗
43. Copper induces cell death by targeting lipoylated TCA cycle proteins10.1126/science.abf0529 ↗
44. Autophagy: a double-edged sword in ischemia-reperfusion injury10.1186/s11658-025-00713-x ↗
45. Coordinated changes in cell membrane and cytoplasm during maturation of apoptotic bleb10.1091/mbc.E19-12-0691 ↗
46. Ferroptosis in cancer and inflammatory diseases: mechanisms and therapeutic implications10.1002/mco2.70349 ↗
47. Hypoxia inducible factor-1α drives cancer resistance to cuproptosis10.1016/j.ccell.2025.02.015 ↗
48. Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1/JNK pathway10.1007/s00432-024-05748-9 ↗
49. Hypoxia-induced autophagy: cell death or cell survival?10.1016/j.ceb.2009.11.015 ↗
50. Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy10.1038/ncb2536 ↗
51. Hepatic gluconeogenesis and PDK3 upregulation drive cancer cachexia in flies and mice10.1038/s42255-025-01265-2 ↗
52. KDM4A coactivates E2F1 to regulate the PDK-dependent metabolic switch between mitochondrial oxidation and glycolysis10.1016/j.celrep.2016.08.018 ↗
53. Depletion of zinc causes osteoblast apoptosis with elevation of leptin secretion and phosphorylation of JAK2/STAT310.3390/nu15010077 ↗
54. Abnormal mechanical load aggravates subchondral bone remodeling and uneven tibial plateau settlement in knee osteoarthritis via activation of osteoblast Piezo1-Ca2+-JAK2/STAT3 signaling10.7150/ijbs.124507 ↗
55. ALKBH7 mediates the mitigative effect of bismuth drug against cisplatin-induced acute kidney injury10.1016/j.bcp.2025.117045 ↗
56. Targeting N-methyl-lysine histone demethylase KDM4 in cancer: natural products inhibitors as a driving force for epigenetic drug discovery10.1002/cmdc.202400682 ↗
57. PDK3 drives colorectal carcinogenesis and immune evasion and is a therapeutic target for boosting immunotherapy10.62347/QWKZ3078 ↗
58. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis10.1111/jop.12440 ↗
59. Hydrogel-forming microneedles with applications in oral diseases management10.3390/ma16134805 ↗
60. Lidocaine-loaded dissolving microneedle for safe local anesthesia on oral mucosa for dental procedure10.1080/17425247.2023.2216450 ↗
61. Multifunctional photodynamic/photothermal nano-agents for the treatment of oral leukoplakia10.1186/s12951-022-01310-2 ↗
62. The purpose and ubiquity of turnover10.1016/j.cell.2024.04.034 ↗
63. Manganese suppresses the development of oral leukoplakia by activating the immune response10.1111/odi.14412 ↗
64. Tough and waterproof microneedles overcome mucosal immunotolerance by modulating antigen release patterns10.1016/j.jconrel.2025.113740 ↗
65. Mitochondria-associated pathways in cancer and precancerous conditions: mechanistic insights10.3390/ijms26178537 ↗
66. Autophagy analysis in oral carcinogenesis10.1016/j.prp.2017.07.027 ↗
67. Expression and clinical significance of PDK family in breast cancer based on data mining
68. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/210.1158/0008-5472.CAN-07-5156 ↗
69. A comparative study of the effects of three modes of 4-Nitroquinoline N-oxide induction of sprague dawley rats in animal models of oral leukoplakia
70. Bismuth release from endodontic materials: proposed mechanisms for systemic circulation and organ accumulation10.1016/j.jhazmat.2025.138580 ↗
71. A counterion-free strategy for chronic metabolic acidosis based on an orally administered gut-restricted inorganic adsorbent10.1002/adma.202305992 ↗